Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients ; volume:14 ; number:1 ; day:13 ; month:1 ; year:2014 ; pages:1-7 ; date:12.2014
BMC infectious diseases ; 14, Heft 1 (13.1.2014), 1-7, 12.2014
- Creator
-
Fabbiani, Massimiliano
- Contributor
-
Zaccarelli, Mauro
Grima, Pierfrancesco
Prosperi, Mattia
Fanti, Iuri
Colafigli, Manuela
D’Avino, Alessandro
Mondi, Annalisa
Borghetti, Alberto
Fantoni, Massimo
Cauda, Roberto
Di Giambenedetto, Simona
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-14-26
- URN
-
urn:nbn:de:1111-2016030314772
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fabbiani, Massimiliano
- Zaccarelli, Mauro
- Grima, Pierfrancesco
- Prosperi, Mattia
- Fanti, Iuri
- Colafigli, Manuela
- D’Avino, Alessandro
- Mondi, Annalisa
- Borghetti, Alberto
- Fantoni, Massimo
- Cauda, Roberto
- Di Giambenedetto, Simona
- SpringerLink (Online service)
Other Objects (12)
Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
Simplification of therapy (ART) with efavirenz/emtricitabine/tenofovir DF single tablet regimen vs. continued ART in suppressed, HIV-infected patients
Modular Titratable Polypills for Personalized Medicine and Simplification of Complex Medication Regimens
Simplification
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d’Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial
Impact of CYP2B6 and CYP2A6 polymorphisms on efavirenz plasma concentrations in Ghanaian HIV-infected patients
Patient-reported outcomes after simplification to a single tablet regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir DF (TDF)
Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz
Randomization and Simplification
Correction to: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
Simplification of therapy (ART) with efavirenz/emtricitabine/tenofovir DF single tablet regimen vs. continued ART in suppressed, HIV-infected patients
Modular Titratable Polypills for Personalized Medicine and Simplification of Complex Medication Regimens
Simplification
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d’Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial
Impact of CYP2B6 and CYP2A6 polymorphisms on efavirenz plasma concentrations in Ghanaian HIV-infected patients
Patient-reported outcomes after simplification to a single tablet regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir DF (TDF)
Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz
Randomization and Simplification
Correction to: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
Simplification of therapy (ART) with efavirenz/emtricitabine/tenofovir DF single tablet regimen vs. continued ART in suppressed, HIV-infected patients
Modular Titratable Polypills for Personalized Medicine and Simplification of Complex Medication Regimens
Simplification
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d’Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial
Impact of CYP2B6 and CYP2A6 polymorphisms on efavirenz plasma concentrations in Ghanaian HIV-infected patients
Patient-reported outcomes after simplification to a single tablet regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir DF (TDF)
Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz
Randomization and Simplification